CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Sana Biotechnology, Inc. - SANA CFD

6.34
7.17%
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-0.26)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.04)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 50%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 6.83
Open 6.52
1-Year Change 13.59%
Day's Range 6.2 - 6.52
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 16, 2024 6.83 0.40 6.22% 6.43 7.37 6.43
Jul 15, 2024 6.32 0.33 5.51% 5.99 6.58 5.92
Jul 12, 2024 5.91 0.26 4.60% 5.65 6.04 5.64
Jul 11, 2024 5.62 0.30 5.64% 5.32 5.75 5.32
Jul 10, 2024 5.14 -0.09 -1.72% 5.23 5.23 5.10
Jul 9, 2024 5.19 0.21 4.22% 4.98 5.21 4.93
Jul 8, 2024 5.05 -0.04 -0.79% 5.09 5.16 4.91
Jul 5, 2024 5.06 -0.10 -1.94% 5.16 5.19 4.92
Jul 3, 2024 5.18 -0.04 -0.77% 5.22 5.44 5.13
Jul 2, 2024 5.31 -0.11 -2.03% 5.42 5.43 5.19
Jul 1, 2024 5.43 0.04 0.74% 5.39 5.56 5.31
Jun 28, 2024 5.41 0.15 2.85% 5.26 5.51 5.25
Jun 27, 2024 5.36 0.30 5.93% 5.06 5.36 5.01
Jun 26, 2024 5.22 -0.24 -4.40% 5.46 5.47 5.06
Jun 25, 2024 5.38 -0.11 -2.00% 5.49 5.57 5.37
Jun 24, 2024 5.50 0.04 0.73% 5.46 5.69 5.42
Jun 21, 2024 5.47 0.25 4.79% 5.22 5.52 5.19
Jun 20, 2024 5.19 -0.41 -7.32% 5.60 5.60 5.18
Jun 18, 2024 5.65 -0.28 -4.72% 5.93 5.96 5.62
Jun 17, 2024 5.96 -0.07 -1.16% 6.03 6.22 5.79

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Sana Biotechnology, Inc. Company profile

About Sana Biotechnology Inc

Sana Biotechnology, Inc is a preclinical-stage biotechnology company. The Company is focused on creating and delivering engineered cells as medicines for patients. The Company develops in vivo and ex vivo cell engineering platforms for treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. The Company’s process of repairing and controlling genes in the body, referred to as gene therapy or in vivo cell engineering, requires in vivo delivery of a therapeutic payload and modification of the genome. The Company’s fusogen technology in preclinical studies targets cell surface receptors when combined with delivery vehicles to form fusosomes and allows cell-specific delivery across multiple different cell types. It focuses this technology on delivering payloads to T cells, hepatocytes, and hematopoietic stem cells (HSCs).

Financial summary

BRIEF: For the nine months ended 30 September 2021, Sana Biotechnology Inc revenues was not reported. Net loss increased 42% to $245.2M. Higher net loss reflects Personnel increase of 36% to $55.2M (expense), General and administrative - Balancing increase of 80% to $32.6M (expense), Stock-based Compensation in R&D increase from $2.6M to $9.9M (expense).

Industry: Biotechnology & Medical Research (NEC)

188 East Blaine Street, Suite 400
SEATTLE
WASHINGTON 98102
US

People also watch

BTC/USD

64,495.90 Price
-0.430% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.63 Price
+7.490% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,418.54 Price
-0.730% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

19,825.30 Price
-2.770% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading